WO2009090027A3 - Trägerpellets, verfahren zu deren herstellung und deren verwendung - Google Patents

Trägerpellets, verfahren zu deren herstellung und deren verwendung Download PDF

Info

Publication number
WO2009090027A3
WO2009090027A3 PCT/EP2009/000124 EP2009000124W WO2009090027A3 WO 2009090027 A3 WO2009090027 A3 WO 2009090027A3 EP 2009000124 W EP2009000124 W EP 2009000124W WO 2009090027 A3 WO2009090027 A3 WO 2009090027A3
Authority
WO
WIPO (PCT)
Prior art keywords
production
carrier pellets
carrier
pellets
active ingredients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2009/000124
Other languages
English (en)
French (fr)
Other versions
WO2009090027A2 (de
WO2009090027A8 (de
Inventor
Antje Weigt
Wolfgang Kempe
Burkhard Schlütermann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADD Advanced Drug Delivery Technologies AG
Ipc Process-Center & Co KG GmbH
Original Assignee
ADD Advanced Drug Delivery Technologies AG
Ipc Process-Center & Co KG GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to DK09702374.1T priority Critical patent/DK2244696T3/en
Priority to SI200931304T priority patent/SI2244696T1/sl
Priority to HRP20151132TT priority patent/HRP20151132T1/hr
Priority to US12/863,336 priority patent/US20110097411A1/en
Priority to EP09702374.1A priority patent/EP2244696B1/de
Priority to PL09702374T priority patent/PL2244696T3/pl
Priority to ES09702374.1T priority patent/ES2552172T3/es
Application filed by ADD Advanced Drug Delivery Technologies AG, Ipc Process-Center & Co KG GmbH filed Critical ADD Advanced Drug Delivery Technologies AG
Publication of WO2009090027A2 publication Critical patent/WO2009090027A2/de
Publication of WO2009090027A8 publication Critical patent/WO2009090027A8/de
Publication of WO2009090027A3 publication Critical patent/WO2009090027A3/de
Anticipated expiration legal-status Critical
Priority to US14/209,056 priority patent/US11191726B2/en
Priority to US14/680,281 priority patent/US20150209286A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Die Erfindung betrifft ein Verfahren zur Herstellung von Trägerpellets für arzneiliche Wirkstoffe. Ebenso betrifft die Erfindung derartige Trägerpellets, sowie diese enthaltende pharmazeutische Formulierungen. Verwendung finden die erfindungsgemäßen Trägerpellets für den Transport und die Freisetzung von arzneilichen Wirkstoffen, insbesondere im menschlichen Körper.
PCT/EP2009/000124 2008-01-17 2009-01-12 Trägerpellets, verfahren zu deren herstellung und deren verwendung Ceased WO2009090027A2 (de)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ES09702374.1T ES2552172T3 (es) 2008-01-17 2009-01-12 Minigránulos portadores, procedimiento para su fabricación y su uso
HRP20151132TT HRP20151132T1 (hr) 2008-01-17 2009-01-12 Peleti kao nosaäśi, postupak njihove proizvodnje i njihove uporabe
US12/863,336 US20110097411A1 (en) 2008-01-17 2009-01-12 Carrier pellets, method for production thereof and use thereof
EP09702374.1A EP2244696B1 (de) 2008-01-17 2009-01-12 Trägerpellets, verfahren zu deren herstellung und deren verwendung
PL09702374T PL2244696T3 (pl) 2008-01-17 2009-01-12 Granulki nośnikowe, sposób ich wytwarzania i ich zastosowanie
DK09702374.1T DK2244696T3 (en) 2008-01-17 2009-01-12 Bærerpellets, process for the preparation thereof and use thereof
SI200931304T SI2244696T1 (sl) 2008-01-17 2009-01-12 Nosilni peleti, metoda za njihovo proizvodnjo in njihovo uporabo
US14/209,056 US11191726B2 (en) 2008-01-17 2014-03-13 Carrier pellets, method for production thereof and use thereof
US14/680,281 US20150209286A1 (en) 2008-01-17 2015-04-07 Carrier pellets, method for production thereof and use thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102008004893A DE102008004893A1 (de) 2008-01-17 2008-01-17 Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
DE102008004893.3 2008-01-17

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US12/863,336 A-371-Of-International US20110097411A1 (en) 2008-01-17 2009-01-12 Carrier pellets, method for production thereof and use thereof
US14/209,056 Continuation US11191726B2 (en) 2008-01-17 2014-03-13 Carrier pellets, method for production thereof and use thereof

Publications (3)

Publication Number Publication Date
WO2009090027A2 WO2009090027A2 (de) 2009-07-23
WO2009090027A8 WO2009090027A8 (de) 2009-10-08
WO2009090027A3 true WO2009090027A3 (de) 2010-05-06

Family

ID=40473941

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2009/000124 Ceased WO2009090027A2 (de) 2008-01-17 2009-01-12 Trägerpellets, verfahren zu deren herstellung und deren verwendung

Country Status (12)

Country Link
US (3) US20110097411A1 (de)
EP (2) EP2244696B1 (de)
CY (1) CY1117126T1 (de)
DE (1) DE102008004893A1 (de)
DK (1) DK2244696T3 (de)
ES (1) ES2552172T3 (de)
HR (1) HRP20151132T1 (de)
HU (1) HUE026364T2 (de)
PL (1) PL2244696T3 (de)
PT (1) PT2244696E (de)
SI (1) SI2244696T1 (de)
WO (1) WO2009090027A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025240494A1 (en) 2024-05-13 2025-11-20 Lumen Bioscience, Inc. Leptin compositions and methods of making and using the same to support weight loss and/or maintenance

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016078A1 (de) * 1995-10-27 1997-05-09 Givaudan-Roure (International) S.A. Aromengranulat
US5902844A (en) * 1998-02-02 1999-05-11 Applied Analytical Industries, Inc. Spray drying of pharmaceutical formulations containing amino acid-based materials
EP1262198A1 (de) * 2001-05-29 2002-12-04 Pharma Pass S.A. Kombination von Carbidopa und Levodopa mit verzögerter Wirkstoffabgabe
US6492024B1 (en) * 1999-06-29 2002-12-10 Aeromatic-Fielder Ag Precision granulation
EP1317925A1 (de) * 2001-12-06 2003-06-11 ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. Mikrogranulate von Ursodeoxycholsäure
US20050163855A1 (en) * 2004-01-27 2005-07-28 Cj Corporation Method of preparing low-crystallinity oltipraz or amorphous oltipraz
WO2006052503A2 (en) * 2004-11-04 2006-05-18 Merck & Co Inc Process for granulating particles
JP2007297313A (ja) * 2006-04-28 2007-11-15 Lion Corp 生薬造粒粒子の製造方法および生薬造粒粒子、錠剤
EP1958520A2 (de) * 2007-02-09 2008-08-20 Symrise GmbH & Co. KG Wirbelschichtgranulate mit hohem Fruchtanteil

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN172051B (de) * 1987-12-11 1993-03-27 Hoechst Ag
JP2880243B2 (ja) * 1989-04-18 1999-04-05 武田薬品工業株式会社 アスコルビン酸カルシウム造粒物
MY117538A (en) 1997-05-28 2004-07-31 Isegen South Africa Proprietary Ltd Production of a food acid mixture containing fumaric acid
DE19733094A1 (de) * 1997-07-31 1999-02-04 Merck Patent Gmbh Formulierung auf der Basis von Ascorbinsäure mit verbesserter Farbstabilität
DK0901786T3 (da) * 1997-08-11 2007-10-08 Pfizer Prod Inc Faste farmaceutiske dispersioner med foröget biotilgængelighed
TWI223598B (en) * 1998-06-22 2004-11-11 Pfizer Ireland Pharmaceuticals An intranasal pharmaceutical composition for the treatment of male erectile dysfunction or female sexual disorders, an intranasal delivery system or device and sildenafil mesylate
JP4290792B2 (ja) * 1999-01-11 2009-07-08 カルピス株式会社 造粒物、その製法及びこれを用いた錠剤
US20020193301A1 (en) * 1999-08-19 2002-12-19 Stem Cell Pharmaceuticals, Inc. TGF-alpha polypeptides, functional fragments and methods of use therefor
GB0003782D0 (en) * 2000-02-17 2000-04-05 Dumex Ltd As Process
DE10012199A1 (de) * 2000-03-13 2001-09-20 Haarmann & Reimer Gmbh Eingekapselte Substanzen mit kontrollierter Freisetzung
JP2001294524A (ja) * 2000-04-12 2001-10-23 Taisho Pharmaceut Co Ltd アセトアミノフェン配合内服固形製剤
CA2443089C (en) * 2001-04-03 2011-11-01 Schering Corporation Antifungal suspension of micronized posaconazole
DE10209982A1 (de) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe
DE10322062A1 (de) * 2003-05-15 2004-12-02 Glatt Ingenieurtechnik Gmbh Verfahren und Vorrichtung zum Aufbringen von Flüssigkeiten in eine Feststoffströmung eines Strahlschichtapparates
DE10325989A1 (de) * 2003-06-07 2005-01-05 Glatt Gmbh Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
CN101111230B (zh) * 2005-03-29 2010-05-19 赢创罗姆有限责任公司 包含对活性成分具有调节释放作用的小丸的多颗粒药用形式
US20070281927A1 (en) * 2006-06-06 2007-12-06 Shanthakumar Tyavanagimatt Anti-inflammatory and analgesic compositions and related methods
BRPI0716439B8 (pt) * 2006-08-14 2021-05-25 Boehringer Ingelheim Int sistemas de liberação farmacêutico compreendendo flibanserina, processo para preparação e uso dos mesmos

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997016078A1 (de) * 1995-10-27 1997-05-09 Givaudan-Roure (International) S.A. Aromengranulat
US5902844A (en) * 1998-02-02 1999-05-11 Applied Analytical Industries, Inc. Spray drying of pharmaceutical formulations containing amino acid-based materials
US6492024B1 (en) * 1999-06-29 2002-12-10 Aeromatic-Fielder Ag Precision granulation
EP1262198A1 (de) * 2001-05-29 2002-12-04 Pharma Pass S.A. Kombination von Carbidopa und Levodopa mit verzögerter Wirkstoffabgabe
EP1317925A1 (de) * 2001-12-06 2003-06-11 ISTITUTO BIOCHIMICO ITALIANO GIOVANNI LORENZINI S.p.A. Mikrogranulate von Ursodeoxycholsäure
US20050163855A1 (en) * 2004-01-27 2005-07-28 Cj Corporation Method of preparing low-crystallinity oltipraz or amorphous oltipraz
WO2006052503A2 (en) * 2004-11-04 2006-05-18 Merck & Co Inc Process for granulating particles
JP2007297313A (ja) * 2006-04-28 2007-11-15 Lion Corp 生薬造粒粒子の製造方法および生薬造粒粒子、錠剤
EP1958520A2 (de) * 2007-02-09 2008-08-20 Symrise GmbH & Co. KG Wirbelschichtgranulate mit hohem Fruchtanteil

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE CA CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; 6 December 2007 (2007-12-06), XP002555058, Database accession no. 147:528145 *
JACOB ET AL: "ProCell technology: Modelling and application", POWDER TECHNOLOGY, ELSEVIER SEQUOIA, LAUSANNE, CH, vol. 189, no. 2, 31 January 2009 (2009-01-31), pages 332 - 342, XP025884765, ISSN: 0032-5910, [retrieved on 20080424] *
KORAKIANITI E S ET AL: "Sequential optimization of a pelletization process in a fluid bed rotor granulator", JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, ED. DE SANTÉ, FR, vol. 14, no. 3, 1 May 2004 (2004-05-01), pages 207 - 214, XP008114543, ISSN: 1773-2247 *
ONEDA F ET AL: "The effect of formulation variables on the dissolution and physical properties of spray-dried microspheres containing organic salts", POWDER TECHNOLOGY, ELSEVIER SEQUOIA, LAUSANNE, CH, no. 130, 1 January 2003 (2003-01-01), pages 377 - 384, XP002429927, ISSN: 0032-5910 *

Also Published As

Publication number Publication date
PL2244696T3 (pl) 2016-01-29
US20110097411A1 (en) 2011-04-28
HUE026364T2 (en) 2016-06-28
HRP20151132T1 (hr) 2015-12-18
EP2244696A2 (de) 2010-11-03
SI2244696T1 (sl) 2016-01-29
US11191726B2 (en) 2021-12-07
ES2552172T3 (es) 2015-11-26
EP2244696B1 (de) 2015-08-05
EP2949320A1 (de) 2015-12-02
US20150209286A1 (en) 2015-07-30
DK2244696T3 (en) 2015-11-09
CY1117126T1 (el) 2017-04-05
WO2009090027A2 (de) 2009-07-23
US20140193509A1 (en) 2014-07-10
DE102008004893A1 (de) 2009-07-23
PT2244696E (pt) 2015-11-19
WO2009090027A8 (de) 2009-10-08

Similar Documents

Publication Publication Date Title
WO2011061330A3 (de) Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe
WO2009117130A3 (en) Extended release forumulation containing a wax
ZA200809864B (en) Pharmaceutical formulations for the sustained release of active ingredients(s), as well as their applications, especially therapeutic
WO2010021607A3 (en) Pharmaceutical formulation
WO2009109927A3 (en) Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer
ZA200807778B (en) Reverse-Phase microcapsules for active ingredients, simplified process of manufacture thereof and combined formulations WDG-CS, ZC, EC-SC and CX
WO2007067044A3 (en) Modified active-ingredient-containing pellets/capsules
IL220679A (en) Method of manufacture of solid preparations containing basic active pharmaceutical ingredients and the solid preparations produced by the method
WO2009025926A3 (en) Nanoparticle-coated medical devices and formulations for treating vascular disease
IL222578A0 (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
WO2009135855A3 (en) Encapsulation of biologically active agents
NZ612722A (en) Hop extract oxidation-reaction product, preparing method thereof and use thereof
WO2010046061A3 (de) Kosmetische und/oder pharmazeutische zubereitungen
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
WO2009059712A3 (de) Homogene und lagerstabile mischungen unterschiedlicher pflanzenschutzmittel-wirkstoff-granulatpartikel
WO2008110374A3 (de) Pellets enthaltend pharmazeutische substanz, verfahren zu deren herstellung und deren verwendung
WO2011103920A3 (en) Pharmaceutical or neutraceutical formulation
HK1199841A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013170086A3 (en) Formulations for the delivery of active ingredients
GB2443793B (en) Product, method of manufacture and use
WO2011127244A3 (en) ATAZANAVIR SULFATE FORMULATIONS WITH IMPROVED pH EFFECT
WO2008092219A3 (en) Pharmaceutical composition comprising tramadol and ketoprofen
MX2011006721A (es) Formulacion farmaceutica de fenofibrato nanonizado.
WO2010149283A3 (de) Phenyloxy(thio)phenylamidbenzoxa(thia)zole

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09702374

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 5149/DELNP/2010

Country of ref document: IN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009702374

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12863336

Country of ref document: US